dos Reis Ricardo, Frumovitz Michael, Milam Michael R, Capp Edison, Sun Charlotte C, Coleman Robert L, Ramirez Pedro T
Hospital de Clinicas de Porto Alegre, Gynecologic Oncology Service, Universidade Federal do Rio Grande do Sul, Ramiro Barcelos 2350, Porto Alegre, Brazil.
Gynecol Oncol. 2007 Dec;107(3):458-63. doi: 10.1016/j.ygyno.2007.07.080. Epub 2007 Sep 12.
To evaluate whether histology (adenocarcinoma versus adenosquamous carcinoma) is an independent prognostic indicator in patients with stage IB1 cervical cancer after radical hysterectomy.
All patients with adenocarcinoma or adenosquamous carcinoma who underwent radical hysterectomy between October 1990 and December 2006 at The University of Texas M. D. Anderson Cancer Center were evaluated. Clinico-pathological data collected included age, disease stage, tumor grade, lymph node status, parametrial involvement, depth of invasion, evidence of lymph-vascular space invasion (LVSI), and adjuvant therapy. Patients were categorized as having "low-risk" or "high-risk" disease depending on the final pathologic findings.
We identified 126 patients with stage IB1 adenosquamous (n=29) or adenocarcinoma (n=97) cervical cancer. The median follow-up was 79 months (range 1.7-184.6). The median age was 40.3 years for patients with adenocarcinoma and 35.2 years for patients with adenosquamous carcinoma (P=0.88). Grade III histology and LVSI were more common in patients with adenosquamous tumors than in patients with adenocarcinoma (85% versus 16%; P<0.01 and 56.5% versus 32.8; P=0.04). Histology was not associated with lymph node or parametrial involvement. There was no difference in recurrence rates between the two histologic groups, but the time to recurrence was shorter for patients with adenosquamous carcinoma (7.9 months versus 15 months; P=0.01). There was no difference between cell types with regards to recurrence and recurrence-free survival rates in the low- and high-risk groups.
We found no evidence that histologic subtype affects outcome; however, the median time to recurrence was shorter in patients with adenosquamous carcinoma. Our study suggests that in patients with stage IB1 adenosquamous carcinoma or adenocarcinoma, the presence of high-risk features is more important than histologic subtype.
评估组织学类型(腺癌与腺鳞癌)是否为根治性子宫切除术后IB1期宫颈癌患者的独立预后指标。
对1990年10月至2006年12月在德克萨斯大学MD安德森癌症中心接受根治性子宫切除术的所有腺癌或腺鳞癌患者进行评估。收集的临床病理数据包括年龄、疾病分期、肿瘤分级、淋巴结状态、宫旁组织受累情况、浸润深度、淋巴血管间隙浸润(LVSI)证据及辅助治疗。根据最终病理结果将患者分为“低风险”或“高风险”疾病。
我们确定了126例IB1期腺鳞癌(n = 29)或腺癌(n = 97)宫颈癌患者。中位随访时间为79个月(范围1.7 - 184.6个月)。腺癌患者的中位年龄为40.3岁,腺鳞癌患者为35.2岁(P = 0.88)。腺鳞癌患者中III级组织学和LVSI比腺癌患者更常见(85%对16%;P < 0.01和56.5%对32.8%;P = 0.04)。组织学类型与淋巴结或宫旁组织受累无关。两组组织学类型的复发率无差异,但腺鳞癌患者的复发时间较短(7.9个月对15个月;P = 0.01)。在低风险和高风险组中,细胞类型在复发率和无复发生存率方面无差异。
我们没有发现组织学亚型影响预后的证据;然而,腺鳞癌患者的中位复发时间较短。我们的研究表明,对于IB1期腺鳞癌或腺癌患者,高风险特征的存在比组织学亚型更重要。